Rapid Bio, a resident of the Skolkovo Foundation (VEB.RF Group), has received the European CE mark – DE/CA09/0170/R26/IVD/001. The express test for Covid-19 antigens became the first Russian-made test to be registered by the European Union. Rapid...
The Skolkovo Foundation and Servier Laboratories are to collaborate in scouting out biotech developers working in the fields of oncology and autoimmune diseases. Signing of MOU. Photo: Sk.ru. Jerome Gavet, the managing director of Russia &...
Insilico Medicine, a Skolkovo resident from the biomedical technologies cluster, is working in collaboration with the Japanese pharmaceutical company Taisho Pharmaceutical. The collaboration is focused on finding a drug for age-related diseases and Taisho Pharmaceutical...
The Skolkovo Foundation online business mission to the Kingdom of Bahrain took place on September 28 with the support of the Embassy of Bahrain in Russia and YBA Kanoo Group, a privately-owned Bahraini business conglomerate. Photo: Sk.ru. The...
Dr. Melita Vujnovic, the World Health Organization (WHO) representative to the Russian Federation, stated during the “Telemedforum-2020” that the organization is interested in Skolkovo resident solutions. During a plenary session, Miss Vujnovic...